APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Tacrolimus Capsules

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Tacrolimus Capsules Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

Report ID 17403953032 January 2026193 pages

Choose your research edition.

Industry ResearchTacrolimus Capsules Industry Research Report 2026124 pages · $2,950 USDIndustry Growth & TrendsGlobal Tacrolimus Capsules Industry Growth and Trends Forecast to 2032102 pages · $3,450 USDMarket StructureGlobal Tacrolimus Capsules Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032193 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Tacrolimus Capsules Market Outlook and Growth Opportunities 2026198 pages · $4,250 USDMarket Analysis & ForecastGlobal Tacrolimus Capsules Market Analysis and Forecast 2026-2032193 pages · $4,950 USD

Market perspective

The global Tacrolimus Capsules market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Tacrolimus Capsules is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Tacrolimus Capsules is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Tacrolimus Capsules is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Tacrolimus Capsules is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Tacrolimus Capsules include Sandoz, Zydus, Torrent, Solco Healthcare, Hikma, Glenmark, Camber Pharmaceuticals, Cadista and Boehringer Ingelheim, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Tacrolimus Capsules market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Tacrolimus Capsules and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Tacrolimus Capsules sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Tacrolimus Capsules market size, projected growth trends, production technologies, key applications, and end-use industries.

Tacrolimus Capsules Segment by Company

Sandoz

Zydus

Torrent

Solco Healthcare

Hikma

Glenmark

Camber Pharmaceuticals

Cadista

Boehringer Ingelheim

Aurobindo

Amneal Pharmaceuticals

Alembic

Tacrolimus Capsules Segment by Type

5mg/pill

1mg/pill

0.5mg/pill

Tacrolimus Capsules Segment by Application

Special Clinic

Hospital

Recovery Center

Tacrolimus Capsules Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Nordic Countries

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Tacrolimus Capsules market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Tacrolimus Capsules and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Tacrolimus Capsules.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Tacrolimus Capsules market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Tacrolimus Capsules manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Tacrolimus Capsules in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Tacrolimus Capsules in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Tacrolimus Capsules Industry Trends Table 2. Tacrolimus Capsules Industry Drivers Table 3. Tacrolimus Capsules Industry Opportunities and Challenges Table 4. Tacrolimus Capsules Industry Restraints Table 5. Global Tacrolimus Capsules Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Tacrolimus Capsules Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Tacrolimus Capsules Sales by Manufacturers (K Units) & (2021-2026) Table 8. Global Tacrolimus Capsules Sales Market Share by Manufacturers Table 9. Global Tacrolimus Capsules Average Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 10. Global Tacrolimus Capsules Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Tacrolimus Capsules Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Tacrolimus Capsules Manufacturers, Product Type & Application Table 13. Global Tacrolimus Capsules Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Tacrolimus Capsules by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of 5mg/pill Table 17. Major Manufacturers of 1mg/pill Table 18. Major Manufacturers of 0.5mg/pill Table 19. Global Tacrolimus Capsules Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 20. Global Tacrolimus Capsules Sales by Type (2021-2026) & (K Units) Table 21. Global Tacrolimus Capsules Sales by Type (2027-2032) & (K Units) Table 22. Global Tacrolimus Capsules Sales Market Share by Type (2021-2026) Table 23. Global Tacrolimus Capsules Sales Market Share by Type (2027-2032) Table 24. Global Tacrolimus Capsules Revenue by Type 2021 VS 2025 VS 2032 (K Units) Table 25. Global Tacrolimus Capsules Revenue by Type (2021-2026) & (K Units) Table 26. Global Tacrolimus Capsules Revenue by Type (2027-2032) & (K Units) Table 27. Global Tacrolimus Capsules Revenue Market Share by Type (2021-2026) Table 28. Global Tacrolimus Capsules Revenue Market Share by Type (2027-2032) Table 29. Major Manufacturers of Special Clinic Table 30. Major Manufacturers of Hospital Table 31. Major Manufacturers of Recovery Center Table 32. Global Tacrolimus Capsules Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 33. Global Tacrolimus Capsules Sales by Application (2021-2026) & (K Units) Table 34. Global Tacrolimus Capsules Sales by Application (2027-2032) & (K Units) Table 35. Global Tacrolimus Capsules Sales Market Share by Application (2021-2026) Table 36. Global Tacrolimus Capsules Sales Market Share by Application (2027-2032) Table 37. Global Tacrolimus Capsules Revenue by Application 2021 VS 2025 VS 2032 (K Units) Table 38. Global Tacrolimus Capsules Revenue by Application (2021-2026) & (K Units) Table 39. Global Tacrolimus Capsules Revenue by Application (2027-2032) & (K Units) Table 40. Global Tacrolimus Capsules Revenue Market Share by Application (2021-2026) Table 41. Global Tacrolimus Capsules Revenue Market Share by Application (2027-2032) Table 42. Global Tacrolimus Capsules Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 43. Global Tacrolimus Capsules Sales by Region (2021-2026) & (K Units) Table 44. Global Tacrolimus Capsules Sales Market Share by Region (2021-2026) Table 45. Global Tacrolimus Capsules Sales Forecasted by Region (2027-2032) & (K Units) Table 46. Global Tacrolimus Capsules Sales Forecasted Market Share by Region (2027-2032) Table 47. North America Tacrolimus Capsules Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 48. North America Tacrolimus Capsules Sales by Country (2021-2026) & (K Units) Table 49. North America Tacrolimus Capsules Sales by Country (2027-2032) & (K Units) Table 50. Europe Tacrolimus Capsules Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 51. Europe Tacrolimus Capsules Sales by Country (2021-2026) & (K Units) Table 52. Europe Tacrolimus Capsules Sales by Country (2027-2032) & (K Units) Table 53. Asia Pacific Tacrolimus Capsules Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 54. Asia Pacific Tacrolimus Capsules Sales by Country (2021-2026) & (K Units) Table 55. Asia Pacific Tacrolimus Capsules Sales by Country (2027-2032) & (K Units) Table 56. South America, Middle East and Africa Tacrolimus Capsules Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 57. South America, Middle East and Africa Tacrolimus Capsules Sales by Country (2021-2026) & (K Units) Table 58. South America, Middle East and Africa Tacrolimus Capsules Sales by Country (2027-2032) & (K Units) Table 59. Global Tacrolimus Capsules Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 60. Global Tacrolimus Capsules Revenue by Region (2021-2026) & (US$ Million) Table 61. Global Tacrolimus Capsules Revenue by Region (2027-2032) & (US$ Million) Table 62. Global Tacrolimus Capsules Revenue Market Share by Region (2021-2026) Table 63. Global Tacrolimus Capsules Revenue Market Share by Region (2027-2032) Table 64. Sandoz Company Information Table 65. Sandoz Business Overview Table 66. Sandoz Tacrolimus Capsules Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 67. Sandoz Tacrolimus Capsules Product Portfolio Table 68. Sandoz Recent Development Table 69. Zydus Company Information Table 70. Zydus Business Overview Table 71. Zydus Tacrolimus Capsules Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 72. Zydus Tacrolimus Capsules Product Portfolio Table 73. Zydus Recent Development Table 74. Torrent Company Information Table 75. Torrent Business Overview Table 76. Torrent Tacrolimus Capsules Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 77. Torrent Tacrolimus Capsules Product Portfolio Table 78. Torrent Recent Development Table 79. Solco Healthcare Company Information Table 80. Solco Healthcare Business Overview Table 81. Solco Healthcare Tacrolimus Capsules Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 82. Solco Healthcare Tacrolimus Capsules Product Portfolio Table 83. Solco Healthcare Recent Development Table 84. Hikma Company Information Table 85. Hikma Business Overview Table 86. Hikma Tacrolimus Capsules Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 87. Hikma Tacrolimus Capsules Product Portfolio Table 88. Hikma Recent Development Table 89. Glenmark Company Information Table 90. Glenmark Business Overview Table 91. Glenmark Tacrolimus Capsules Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 92. Glenmark Tacrolimus Capsules Product Portfolio Table 93. Glenmark Recent Development Table 94. Camber Pharmaceuticals Company Information Table 95. Camber Pharmaceuticals Business Overview Table 96. Camber Pharmaceuticals Tacrolimus Capsules Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 97. Camber Pharmaceuticals Tacrolimus Capsules Product Portfolio Table 98. Camber Pharmaceuticals Recent Development Table 99. Cadista Company Information Table 100. Cadista Business Overview Table 101. Cadista Tacrolimus Capsules Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 102. Cadista Tacrolimus Capsules Product Portfolio Table 103. Cadista Recent Development Table 104. Boehringer Ingelheim Company Information Table 105. Boehringer Ingelheim Business Overview Table 106. Boehringer Ingelheim Tacrolimus Capsules Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 107. Boehringer Ingelheim Tacrolimus Capsules Product Portfolio Table 108. Boehringer Ingelheim Recent Development Table 109. Aurobindo Company Information Table 110. Aurobindo Business Overview Table 111. Aurobindo Tacrolimus Capsules Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 112. Aurobindo Tacrolimus Capsules Product Portfolio Table 113. Aurobindo Recent Development Table 114. Amneal Pharmaceuticals Company Information Table 115. Amneal Pharmaceuticals Business Overview Table 116. Amneal Pharmaceuticals Tacrolimus Capsules Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 117. Amneal Pharmaceuticals Tacrolimus Capsules Product Portfolio Table 118. Amneal Pharmaceuticals Recent Development Table 119. Alembic Company Information Table 120. Alembic Business Overview Table 121. Alembic Tacrolimus Capsules Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 122. Alembic Tacrolimus Capsules Product Portfolio Table 123. Alembic Recent Development Table 124. Key Raw Materials Table 125. Raw Materials Key Suppliers Table 126. Tacrolimus Capsules Distributors List Table 127. Tacrolimus Capsules Customers List Table 128. Research Programs/Design for This Report Table 129. Authors List of This Report Table 130. Secondary Sources Table 131. Primary Sources List of Figures Figure 1. Tacrolimus Capsules Product Image Figure 2. Global Tacrolimus Capsules Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Tacrolimus Capsules Market Size (2021-2032) & (US$ Million) Figure 4. Global Tacrolimus Capsules Sales (2021-2032) & (K Units) Figure 5. Global Tacrolimus Capsules Average Price (US$/Unit) & (2021-2032) Figure 6. Global Top 5 and 10 Tacrolimus Capsules Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. 5mg/pill Image Figure 9. 1mg/pill Image Figure 10. 0.5mg/pill Image Figure 11. Global Tacrolimus Capsules Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 12. Global Tacrolimus Capsules Sales Market Share 2021 VS 2025 VS 2032 Figure 13. Global Tacrolimus Capsules Sales Market Share by Type (2021-2032) Figure 14. Global Tacrolimus Capsules Revenue by Type (2021 VS 2025 VS 2032) & (K Units) Figure 15. Global Tacrolimus Capsules Revenue Market Share 2021 VS 2025 VS 2032 Figure 16. Global Tacrolimus Capsules Revenue Market Share by Type (2021-2032) Figure 17. Special Clinic Image Figure 18. Hospital Image Figure 19. Recovery Center Image Figure 20. Global Tacrolimus Capsules Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 21. Global Tacrolimus Capsules Sales Market Share 2021 VS 2025 VS 2032 Figure 22. Global Tacrolimus Capsules Sales Market Share by Application (2021-2032) Figure 23. Global Tacrolimus Capsules Revenue by Application (2021 VS 2025 VS 2032) & (K Units) Figure 24. Global Tacrolimus Capsules Revenue Market Share 2021 VS 2025 VS 2032 Figure 25. Global Tacrolimus Capsules Revenue Market Share by Application (2021-2032) Figure 26. North America Tacrolimus Capsules Sales and Growth Rate (2021-2032) & (K Units) Figure 27. North America Tacrolimus Capsules Sales Market Share by Country (2021-2032) Figure 28. U.S. Tacrolimus Capsules Sales and Growth Rate (2021-2032) & (K Units) Figure 29. Canada Tacrolimus Capsules Sales and Growth Rate (2021-2032) & (K Units) Figure 30. Mexico Tacrolimus Capsules Sales and Growth Rate (2021-2032) & (K Units) Figure 31. Europe Tacrolimus Capsules Sales and Growth Rate (2021-2032) & (K Units) Figure 32. Europe Tacrolimus Capsules Sales Market Share by Country (2021-2032) Figure 33. Germany Tacrolimus Capsules Sales and Growth Rate (2021-2032) & (K Units) Figure 34. France Tacrolimus Capsules Sales and Growth Rate (2021-2032) & (K Units) Figure 35. U.K. Tacrolimus Capsules Sales and Growth Rate (2021-2032) & (K Units) Figure 36. Italy Tacrolimus Capsules Sales and Growth Rate (2021-2032) & (K Units) Figure 37. Netherlands Tacrolimus Capsules Sales and Growth Rate (2021-2032) & (K Units) Figure 38. Asia Pacific Tacrolimus Capsules Sales and Growth Rate (2021-2032) & (K Units) Figure 39. Asia Pacific Tacrolimus Capsules Sales Market Share by Country (2021-2032) Figure 40. China Tacrolimus Capsules Sales and Growth Rate (2021-2032) & (K Units) Figure 41. Japan Tacrolimus Capsules Sales and Growth Rate (2021-2032) & (K Units) Figure 42. South Korea Tacrolimus Capsules Sales and Growth Rate (2021-2032) & (K Units) Figure 43. Southeast Asia Tacrolimus Capsules Sales and Growth Rate (2021-2032) & (K Units) Figure 44. India Tacrolimus Capsules Sales and Growth Rate (2021-2032) & (K Units) Figure 45. Australia Tacrolimus Capsules Sales and Growth Rate (2021-2032) & (K Units) Figure 46. South America, Middle East and Africa Tacrolimus Capsules Sales and Growth Rate (2021-2032) & (K Units) Figure 47. South America, Middle East and Africa Tacrolimus Capsules Sales Market Share by Country (2021-2032) Figure 48. Brazil Tacrolimus Capsules Sales and Growth Rate (2021-2032) & (K Units) Figure 49. South Africa Tacrolimus Capsules Sales and Growth Rate (2021-2032) & (K Units) Figure 50. Saudi Arabia Tacrolimus Capsules Sales and Growth Rate (2021-2032) & (K Units) Figure 51. Turkey Tacrolimus Capsules Sales and Growth Rate (2021-2032) & (K Units) Figure 52. Argentina Tacrolimus Capsules Sales and Growth Rate (2021-2032) & (K Units) Figure 53. UAE Tacrolimus Capsules Sales and Growth Rate (2021-2032) & (K Units) Figure 54. Egypt Tacrolimus Capsules Sales and Growth Rate (2021-2032) & (K Units) Figure 55. Chile Tacrolimus Capsules Sales and Growth Rate (2021-2032) & (K Units) Figure 56. Global Tacrolimus Capsules Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 57. Global Tacrolimus Capsules Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 58. North America Tacrolimus Capsules Revenue (2021-2032) & (US$ Million) Figure 59. North America Tacrolimus Capsules Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 60. Europe Tacrolimus Capsules Revenue (2021-2032) & (US$ Million) Figure 61. Europe Tacrolimus Capsules Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 62. Asia-Pacific Tacrolimus Capsules Revenue (2021-2032) & (US$ Million) Figure 63. Asia-Pacific Tacrolimus Capsules Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 64. South America, Middle East and Africa Tacrolimus Capsules Revenue (2021-2032) & (US$ Million) Figure 65. South America, Middle East and Africa Tacrolimus Capsules Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 66. Tacrolimus Capsules Value Chain Figure 67. Manufacturing Cost Structure Figure 68. Tacrolimus Capsules Production Mode & Process Figure 69. Direct Comparison with Distribution Share Figure 70. Distributors Profiles Figure 71. Years Considered Figure 72. Research Process Figure 73. Key Executives Interviewed

Scope & coverage.

Types
  • 5mg/pill
  • 1mg/pill
  • 0.5mg/pill
Applications
  • Special Clinic
  • Hospital
  • Recovery Center
Companies covered
  • Sandoz
  • Zydus
  • Torrent
  • Solco Healthcare
  • Hikma
  • Glenmark
  • Camber Pharmaceuticals
  • Cadista
  • Boehringer Ingelheim
  • Aurobindo
  • Amneal Pharmaceuticals
  • Alembic

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Tacrolimus Capsules Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Tacrolimus Capsules Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Tacrolimus Capsules Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Tacrolimus Capsules Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Tacrolimus Capsules Market Dynamics
  1. 2.1 Tacrolimus Capsules Industry Trends
  2. 2.2 Tacrolimus Capsules Industry Drivers
  3. 2.3 Tacrolimus Capsules Industry Opportunities and Challenges
  4. 2.4 Tacrolimus Capsules Industry Restraints
3 Tacrolimus Capsules Market by Manufacturers
  1. 3.1 Global Tacrolimus Capsules Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Tacrolimus Capsules Sales by Manufacturers (2021-2026)
  3. 3.3 Global Tacrolimus Capsules Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Tacrolimus Capsules Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Tacrolimus Capsules Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Tacrolimus Capsules Manufacturers, Product Type & Application
  7. 3.7 Global Tacrolimus Capsules Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Tacrolimus Capsules Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Tacrolimus Capsules Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Tacrolimus Capsules Tier 1, Tier 2, and Tier 3
4 Tacrolimus Capsules Market by Type
  1. 4.1 Tacrolimus Capsules Type Introduction
  2. 4.1.1 5mg/pill
  3. 4.1.2 1mg/pill
  4. 4.1.3 0.5mg/pill
  5. 4.2 Global Tacrolimus Capsules Sales by Type
  6. 4.2.1 Global Tacrolimus Capsules Sales by Type (2021 VS 2025 VS 2032)
  7. 4.2.2 Global Tacrolimus Capsules Sales by Type (2021-2032)
  8. 4.2.3 Global Tacrolimus Capsules Sales Market Share by Type (2021-2032)
  9. 4.3 Global Tacrolimus Capsules Revenue by Type
  10. 4.3.1 Global Tacrolimus Capsules Revenue by Type (2021 VS 2025 VS 2032)
  11. 4.3.2 Global Tacrolimus Capsules Revenue by Type (2021-2032)
  12. 4.3.3 Global Tacrolimus Capsules Revenue Market Share by Type (2021-2032)
5 Tacrolimus Capsules Market by Application
  1. 5.1 Tacrolimus Capsules Application Introduction
  2. 5.1.1 Special Clinic
  3. 5.1.2 Hospital
  4. 5.1.3 Recovery Center
  5. 5.2 Global Tacrolimus Capsules Sales by Application
  6. 5.2.1 Global Tacrolimus Capsules Sales by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Tacrolimus Capsules Sales by Application (2021-2032)
  8. 5.2.3 Global Tacrolimus Capsules Sales Market Share by Application (2021-2032)
  9. 5.3 Global Tacrolimus Capsules Revenue by Application
  10. 5.3.1 Global Tacrolimus Capsules Revenue by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Tacrolimus Capsules Revenue by Application (2021-2032)
  12. 5.3.3 Global Tacrolimus Capsules Revenue Market Share by Application (2021-2032)
6 Global Tacrolimus Capsules Sales by Region
  1. 6.1 Global Tacrolimus Capsules Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Tacrolimus Capsules Sales by Region (2021-2032)
  3. 6.2.1 Global Tacrolimus Capsules Sales by Region (2021-2026)
  4. 6.2.2 Global Tacrolimus Capsules Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Tacrolimus Capsules Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Tacrolimus Capsules Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Tacrolimus Capsules Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Tacrolimus Capsules Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Tacrolimus Capsules Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Tacrolimus Capsules Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Tacrolimus Capsules Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Tacrolimus Capsules Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Tacrolimus Capsules Revenue by Region
  1. 7.1 Global Tacrolimus Capsules Revenue by Region
  2. 7.1.1 Global Tacrolimus Capsules Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Tacrolimus Capsules Revenue by Region (2021-2026)
  4. 7.1.3 Global Tacrolimus Capsules Revenue by Region (2027-2032)
  5. 7.1.4 Global Tacrolimus Capsules Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Tacrolimus Capsules Revenue (2021-2032)
  8. 7.2.2 North America Tacrolimus Capsules Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Tacrolimus Capsules Revenue (2021-2032)
  11. 7.3.2 Europe Tacrolimus Capsules Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Tacrolimus Capsules Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Tacrolimus Capsules Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Tacrolimus Capsules Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Tacrolimus Capsules Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Sandoz
  2. 8.1.1 Sandoz Company Information
  3. 8.1.2 Sandoz Business Overview
  4. 8.1.3 Sandoz Tacrolimus Capsules Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Sandoz Tacrolimus Capsules Product Portfolio
  6. 8.1.5 Sandoz Recent Developments
  7. 8.2 Zydus
  8. 8.2.1 Zydus Company Information
  9. 8.2.2 Zydus Business Overview
  10. 8.2.3 Zydus Tacrolimus Capsules Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Zydus Tacrolimus Capsules Product Portfolio
  12. 8.2.5 Zydus Recent Developments
  13. 8.3 Torrent
  14. 8.3.1 Torrent Company Information
  15. 8.3.2 Torrent Business Overview
  16. 8.3.3 Torrent Tacrolimus Capsules Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Torrent Tacrolimus Capsules Product Portfolio
  18. 8.3.5 Torrent Recent Developments
  19. 8.4 Solco Healthcare
  20. 8.4.1 Solco Healthcare Company Information
  21. 8.4.2 Solco Healthcare Business Overview
  22. 8.4.3 Solco Healthcare Tacrolimus Capsules Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Solco Healthcare Tacrolimus Capsules Product Portfolio
  24. 8.4.5 Solco Healthcare Recent Developments
  25. 8.5 Hikma
  26. 8.5.1 Hikma Company Information
  27. 8.5.2 Hikma Business Overview
  28. 8.5.3 Hikma Tacrolimus Capsules Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Hikma Tacrolimus Capsules Product Portfolio
  30. 8.5.5 Hikma Recent Developments
  31. 8.6 Glenmark
  32. 8.6.1 Glenmark Company Information
  33. 8.6.2 Glenmark Business Overview
  34. 8.6.3 Glenmark Tacrolimus Capsules Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Glenmark Tacrolimus Capsules Product Portfolio
  36. 8.6.5 Glenmark Recent Developments
  37. 8.7 Camber Pharmaceuticals
  38. 8.7.1 Camber Pharmaceuticals Company Information
  39. 8.7.2 Camber Pharmaceuticals Business Overview
  40. 8.7.3 Camber Pharmaceuticals Tacrolimus Capsules Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Camber Pharmaceuticals Tacrolimus Capsules Product Portfolio
  42. 8.7.5 Camber Pharmaceuticals Recent Developments
  43. 8.8 Cadista
  44. 8.8.1 Cadista Company Information
  45. 8.8.2 Cadista Business Overview
  46. 8.8.3 Cadista Tacrolimus Capsules Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Cadista Tacrolimus Capsules Product Portfolio
  48. 8.8.5 Cadista Recent Developments
  49. 8.9 Boehringer Ingelheim
  50. 8.9.1 Boehringer Ingelheim Company Information
  51. 8.9.2 Boehringer Ingelheim Business Overview
  52. 8.9.3 Boehringer Ingelheim Tacrolimus Capsules Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Boehringer Ingelheim Tacrolimus Capsules Product Portfolio
  54. 8.9.5 Boehringer Ingelheim Recent Developments
  55. 8.10 Aurobindo
  56. 8.10.1 Aurobindo Company Information
  57. 8.10.2 Aurobindo Business Overview
  58. 8.10.3 Aurobindo Tacrolimus Capsules Sales, Price, Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Aurobindo Tacrolimus Capsules Product Portfolio
  60. 8.10.5 Aurobindo Recent Developments
  61. 8.11 Amneal Pharmaceuticals
  62. 8.11.1 Amneal Pharmaceuticals Company Information
  63. 8.11.2 Amneal Pharmaceuticals Business Overview
  64. 8.11.3 Amneal Pharmaceuticals Tacrolimus Capsules Sales, Price, Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Amneal Pharmaceuticals Tacrolimus Capsules Product Portfolio
  66. 8.11.5 Amneal Pharmaceuticals Recent Developments
  67. 8.12 Alembic
  68. 8.12.1 Alembic Company Information
  69. 8.12.2 Alembic Business Overview
  70. 8.12.3 Alembic Tacrolimus Capsules Sales, Price, Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Alembic Tacrolimus Capsules Product Portfolio
  72. 8.12.5 Alembic Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Tacrolimus Capsules Value Chain Analysis
  2. 9.1.1 Tacrolimus Capsules Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Tacrolimus Capsules Production Mode & Process
  6. 9.2 Tacrolimus Capsules Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Tacrolimus Capsules Distributors
  9. 9.2.3 Tacrolimus Capsules Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst